Amneal Pharmaceuticals (AMRX) Non-Current Deferred Tax Liability (2017 - 2018)

Amneal Pharmaceuticals' Non-Current Deferred Tax Liability history runs 2 years deep, the most recent figure standing at $1.2 million for Q4 2018.

• In Q4 2018, Non-Current Deferred Tax Liability fell 64.16% year-over-year to $1.2 million; the TTM figure through Dec 2018 stood at $1.2 million (down 64.16% YoY), while the FY2018 annual figure was $1.2 million, down 64.16% from the prior year.
• Non-Current Deferred Tax Liability was $1.2 million for Q4 2018 at Amneal Pharmaceuticals, down from $1.8 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $3.3 million in Q4 2017 to a low of $1.2 million in Q4 2018.